Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.

CONCLUSION: Overall, our study revealed that METTL3 functions as an oncogene in the growth and invasion of osteosarcoma by regulating ATAD2, suggesting a potential therapeutic target for osteosarcoma treatment. PMID: 32044716 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32044716?dopt=Abstract

Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - February 6, 2020 Category: Drugs & Pharmacology Authors: Zhou L, Yang C, Zhang N, Zhang X, Zhao T, Yu J Tags: Biomed Pharmacother Source Type: research